John Sperzel
Chief Executive Officer at T2 BIOSYSTEMS, INC.
Net worth: 1 200 $ as of 31/03/2024
Profile
John J.
Sperzel currently works at T2 Biosystems, Inc., as Chairman, President & Chief Executive Officer from 2021.
Mr. Sperzel also formerly worked at Chembio Diagnostics, Inc., as President, Chief Executive Officer & Director from 2014 to 2017, Chembio Diagnostics, Inc., as President, CEO & Independent Director from 2014 to 2020, ITC Nexus Holding Co., Inc., as Chief Executive Officer from 2011 to 2013, Chembio Diagnostic Systems, Inc., as President, Chief Executive Officer & Director, International Technidyne Corp., as President & Chief Executive Officer from 2011 to 2013, Diadexus, Inc., as Director, Ontera, Inc., as Director, Bayer Diagnostics Corp., as President-Marketing & Business Development from 2000 to 2009, Axis-Shield Ltd., as President-USA, and Roche Diagnostics Corp., as Vice President from 1987 to 1997.
Mr. Sperzel received his undergraduate degree from Plymouth State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
T2 BIOSYSTEMS, INC.
0.01% | 01/03/2024 | 400 ( 0.01% ) | 1 200 $ | 31/03/2024 |
John Sperzel active positions
| Companies | Position | Start |
|---|---|---|
| T2 BIOSYSTEMS, INC. | Chief Executive Officer | 08/01/2020 |
Former positions of John Sperzel
| Companies | Position | End |
|---|---|---|
| CHEMBIO DIAGNOSTICS, INC. | Chief Executive Officer | 09/01/2020 |
| CHEMBIO DIAGNOSTICS, INC. | Chief Executive Officer | 30/05/2017 |
ITC Nexus Holding Co., Inc.
 ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Chief Executive Officer | 01/12/2013 |
International Technidyne Corp.
 International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Chief Executive Officer | 01/12/2013 |
| AXIS-SHIELD LTD | Corporate Officer/Principal | - |
Training of John Sperzel
| Plymouth State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
| Bayer Diagnostics Corp. | Health Technology |
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Health Technology |
Axis-Shield Ltd.
 Axis-Shield Ltd. Medical SpecialtiesHealth Technology Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom. | Health Technology |
Chembio Diagnostic Systems, Inc.
 Chembio Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
International Technidyne Corp.
International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Health Technology |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Ontera, Inc.
 Ontera, Inc. Medical SpecialtiesHealth Technology Ontera, Inc. operates as a biotechnology company which develops single molecule biosensors for diagnostic uses. Its products include sample prep, amplification, measurement, analysis and applications. The firm is a creator of a tiny device that enables detection of any molecule of interest, including nucleic acids, proteins, metabolites, drugs and small molecules. The company was founded by Dan Heller, William Dunbar and Trevor Morin and is headquartered in Santa Cruz, CA. | Health Technology |
- Stock Market
- Insiders
- John Sperzel
